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Objectives: The aims of this study were to investigate the predictive value of an elevated level of alanine
transaminase (ALT) for biliary acute pancreatitis (AP) and to reconsider the role of abdominal ultrasound
(AUS).
Methods: All patients admitted to Christchurch Public Hospital with AP between July 2005 and Decem-
ber 2008 were identified from a prospectively collected database. Peak ALT within 48 h of presentation
was recorded. Aetiology was determined on the basis of history, AUS and other relevant investigations.
Results: A total of 543 patients met the inclusion criteria. Patients with biliary AP had significantly higher
median (range) ALT than those with non-biliary causes (200 units/l [63–421 units/l] vs. 33 units/l
[18–84 units/l]; P < 0.001). An ALT level of >300 units/l had a sensitivity of 36%, specificity of 94%,
positive predictive value of 87% and positive likelihood ratio of 5.6 for gallstones. An elevated ALT and
negative AUS had a probability of 21–80% for gallstones.
Conclusions: An elevated ALT strongly supports a diagnosis of gallstones in AP. Abdominal ultrasound
effectively confirms this diagnosis; however, a negative ultrasound in the presence of a raised ALT does
not exclude gallstones. In some patients consideration could be given to proceeding to laparoscopic
cholecystectomy based on ALT alone.
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Introduction
Acute pancreatitis (AP) is a common surgical presentation.
Gallstones and excessive alcohol consumption are the most
frequent causes of AP and together account for approximately
80% of underlying aetiology.1 Up to 60% of all presentations of
AP are secondary to gallstones.2 Other aetiologies are diverse and
include pancreatic divisum, malignancy, endoscopic retrograde
cholangiopancreatography (ERCP), hypercalcaemia, drug use and
infection.3
The pathophysiology of biliary AP (BAP) remains unclear;
however, common theories of causes include: increased ductal
pressure secondary to a stone lodged in the ampulla of Vater
leading to autodigestion by pancreatic enzymes; reflux of bile into
the pancreas, and sphincter of Oddi incompetence and reflux
of duodenal contents into the pancreatic duct with subsequent
damage to the pancreatic parenchyma.4
The clinical severity of AP ranges from mild to severe, with
an overall mortality of about 10%.4 It is important that biliary
pancreatitis is promptly diagnosed, as specific interventions such
as endoscopic sphincterotomy and cholecystectomy can avoid
complicated and recurrent disease.5
The standard first-line investigation in centres with or without
endoscopic ultrasound (EUS) facilities to determine a biliary aeti-
ology in AP is abdominal ultrasound (AUS). In uncomplicated
cholecystolithiasis, AUS has a sensitivity for gallstones of 92–
98%.6,7 However, in the presence of pancreatitis with associated
ileus and bowel distension, the sensitivity for cholecystolithiasis
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drops to 67–87%.2 The sensitivity of AUS for choledocholithiasis
has been reported to be as low as 20–50%.2 It has been proposed
that alanine transaminase (ALT)may be amore useful predictor of
gallstones in AP than AUS.8 Although EUS is more sensitive and
specific for gallstones and microlithiasis in AP than AUS,7 this
investigation is not widely available in New Zealand. In fact, at
the time of writing there was only one unit in the whole country.
Several biochemical investigations have been proposed to
identify a biliary aetiology, including bilirubin, ALT, alkaline
phosphatase and aspartate transaminase. An elevated ALT is
widely considered the most useful of these markers. A 1994 meta-
analysis found that an ALT level of >150 units/l had a positive
predictive value (PPV) for gallstone pancreatitis of 95%.9 Other
studies using variable thresholds for ALT identified PPVs of 78.8–
100%.8,10,11 A prospective study of 269 patients with BAP found
that 12.3% had a normal ALT and 16.7% had an elevation of less
than three times the upper limit of normal.12
Thus, the aims of this study were to determine the predictive
value of a raised ALT in determining a biliary aetiology in patients
presenting with AP and, in particular, by focusing on the pre- and
post-test probability of a biliary aetiology following AUS, to clarify
the usefulness of AUS in clinical decision making in patients
presenting with AP.
Materials and methods
Patients admitted with their first presentation of pancreatitis
between July 2005 and December 2008 were identified from a
prospectively collected database. Data retrieved included demo-
graphics, predicted severity using Apache (acute physiology and
chronic health evaluation) II scores, investigations performed, sur-
gical treatment and aetiology. Data on peak ALT during the first
48 h after admission were sourced from the hospital’s electronic
clinical information system.
The diagnosis of gallstones was made by AUS, contrast-
enhanced computed tomography (CT) or magnetic resonance
imaging (MRI).Acute pancreatitis secondary to alcohol consump-
tion was diagnosed in patients who reported drinking >40 units of
alcohol per week and in whom gallstones were excluded on AUS.
The centre at which this study was performed does not have
access to EUS and therefore AUS has been the primary imaging
modality used to investigate postulated biliary pancreatitis.
The database had previously met the definition of an audit and
quality assurance tool as per New Zealand national ethics com-
mittee guidelines and therefore its use did not require specific
ethical committee review.13
Statistics and analysis
The group of patients with BAP was compared with a combined
group of patients with AP of non-biliary causes. Continuous
variables are presented as median and range; categorical variables
are shown as a percentage of the total study population. The
Mann–WhitneyU-test was used to compare continuous variables.
The chi-squared test was used for categorical variables. P-values <
0.05 were considered significant. Multivariate analysis was carried
out using logistic regression. The prevalence of gallstones within
the study population was used as the pre-ALT probability of gall-
stones. Likelihood ratios (LRs) for ALT predicting gallstones in
AP at various thresholds were calculated and used to generate
post-ALT probabilities for specific subgroups. Likelihood ratios
for BAP based on positive and negative AUS were derived from a
recent review study, listing sensitivity of 67–87%, specificity of
93%, PPV of 100% and negative predictive value (NPV) of 75%.2
This review paper provided similar data to those seen in earlier
review articles, which listed sensitivity as 62–95%.14,15 The post-
AUS probability of a biliary cause for AP was calculated using the
post-ALT probability of BAP at various ALT thresholds as the
pre-AUS probability. To calculate the post-test probability using
the LR, the pre-test probability (expressed as a value between 0
and 1) was converted into odds (pre-test probability/[1 – pre-test
probability]) and multiplied by the LR to calculate the post-test
odds. This was then converted to the post-test probability
(post-test odds/[1 + post-test odds]). A working example and an
explanation of these calculations are given in Fig. 1.
Results
Atotal of 609patientswere identifiedon thedatabase for theperiod
of July 2005 to December 2008. Sixty patient admissions were
excluded as they represented recurrent presentations to hospital
withAP;fivewere excludedbecause anALTwasnotperformed,and
onewas excluded as the national hospital index number was stored
inaccurately on the database. This left a total of 543 patients for
analysis. Demographics and investigations are shown in Table 1.
The use of MRI is not shown as it was not specifically recorded
in the database. The relative frequencies of the various aetiologies
are shown in Table 2. Univariate analyses comparing biliary vs.
non-biliary aetiologies are shown in Table 3. Logistic regression
identified age (P < 0.001),ALT (P < 0.001) and gender (P = 0.0412)
as independent predictors of a biliary cause in AP.
Table 4 demonstrates the diagnostic value of age, gender and
ALT at different thresholds using sensitivity, specificity, PPV, NPV
and LRs. Table 5 uses the pre-ALT test probabilities for the study
population and relevant subgroups, and the LRs generated at
different ALT thresholds, to determine the post-ALT test probabil-
ity of gallstones in AP. Table 6 demonstrates the probability of a
biliary cause for AP at various ALT thresholds in the presence of
a positive or negative AUS, based on the sensitivity and specificity
of AUS in a review paper.2
Discussion
The current study has demonstrated that a raised ALT within 48 h
of presentation to hospital is strongly predictive of a biliary origin
in AP. The higher the ALT, the more likely a biliary cause becomes.
This finding is supported by a number of previous studies which
found that the predictive value of ALT is even greater than that
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demonstrated by this study. In the present cohort of patients, an
ALT of >150 units/l had a PPV for gallstones of 81%, compared
with a 1994meta-analysis which found a PPV of 95% for the same
ALT level.9 More recent studies have found that ALT levels that are
three times the normal level or >150 units/l have PPVs for gall-
stones of 92–93%.16,17 Another study found that an ALT of >60
units/l had a PPV for gallstones in AP of 78.8%.18 Other studies
have not presented data for higher ALT thresholds.
Consistent with previous studies,16,17 female gender (P =
0.0417) and increasing age (P < 0.0001) were shown to be inde-
pendent risk factors for gallstones in AP. Thus, combining these
factors with ALT results in a modest increase in the predictive
power for gallstones in AP (Table 5).
The positive and negative predictive values of a test are related
not only to its sensitivity (NPV) and specificity (PPV), but also to
Take 100 hypothetical pancreatitis patients and say, for example, that we expect 60 of them have a biliary cause. We can formalize the notion of 
how likely a given patient is to be in the biliary group in two ways:
(1) Probability (P) = number with biliary cause/total number of patients = 60/100 = 0.6
(2) Odds (O) = number with biliary cause/number without biliary cause
 = 60/40 = 1.5 (odds ratio = 1.5 : 1) 
Whereas probabilities are numbers between 0 and 1, odds are numbers between 0 and infinity 
Although many people are more familiar with probability, odds convey the same information in a different format that can become familiar 
through use, as many sports gamblers know. Higher odds correspond to higher probabilities. A probability of 0.5 is equivalent to odds of 1
The probability of an event occurring can be converted to odds of that event and vice versa via simple mathematical equations:
(3a) O = P/(1 -  P) = the probability of the event happening/the probability of it not happening 
(3b) P = O/(1 + O)
A likelihood ratio (LR) is a number between 0 and infinity that is a ratio of odds, particularly in the context of a diagnostic test (‘odds ratio’
describes a similar concept concerning exposures and risk) 
(4a) LR = post-test odds/pre-test odds 
Thus: 
(4b) Pre-test odds × LR = post-test odds 
If we combine equations (3a), (3b) and (4b), we can use an LR to generate a post-test probability from a pre-test probability. This quantifies the  
decision process of ‘how much more or less likely is this diagnosis given that test result?’ in a way that is far more intuitive than sensitivity.
Unlike positive and negative predictive values, the LR is independent of the prevalence of a given condition
The LR is derived from equation (4a), but can be shown to be equivalent to sensitivity/(1 - specificity) 
Take, for example, our 100 pancreatitis patients and say they all have an ALT level > 150 units/l, which has an LR of 4. We can
 
(5) pre-ALT odds = pre-test probability/(1 - pre-test probability) (from 3a)
  = 0.6/(1 •  0.6) = 1.5 
(6) post-ALT probability = post-test odds/(1 + post-test odds) (from 3b)
   = pre-test odds × LR/(1 + pre-test odds × LR) (from 4b) 
   = 1.5 × 4/(1 + 1.5 × 4) 
   = 0.86 
That is, an ALT level of > 150 units/l with an LR of 4 increases the probability of a biliary cause from 0.6 to 0.86
calculate a post-test probability as follows:
Figure 1 An example of probability, odds and likelihood ratio. ALT, alanine transaminase
Table 1 Demographics of and investigations performed in the study
population (n = 543)
Demographics and investigations
Median age, years (range) 57 (40–72)
Female, n (%) 283 (52)
Abdominal ultrasound, n (%) 448 (84)
Computed tomography, n (%) 156 (29)
Table 2 Aetiology of acute pancreatitis in patients presenting with
first episodes of acute pancreatitis at Christchurch Hospital between
July 2005 and December 2008 (n = 543)
Aetiology Patients, n %
Gallstones 292 53.8
Unknown 131 24.1
Alcohol 53 9.8
Other 39 7.2
ERCP 14 2.6
SOD 7 1.3
Pancreatic cancer 3 0.6
Pancreatic divisum 2 0.4
Trauma 2 0.4
ERCP, endoscopic retrograde cholangiopancreatography; SOD, sphinc-
ter of Oddi dysfunction
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the incidence or prevalence of a condition within the population.
Thus, in a population in which the incidence of a biliary aetiology
is 54% and the pre-AUS test probability of gallstones in those
with an elevated ALT is 65–92% (Table 6), the post-AUS test
probability approaches 100% for patients with a positive AUS, but
patients with a negative AUS still have a 21–80% probability of
their underlying aetiology being biliary (Table 6). Thus, one could
argue that cholecystectomy be considered in all patients with an
elevated ALT.
Although AUS carries no risk and is inexpensive and readily
available, it risks the possibility that a negative result will be inter-
preted as a reason not to perform cholecystectomy, although
21–80% of these patients will have a biliary aetiology depending
on the level of ALT. This risk is further underlined by data indi-
cating that untreated BAP has been associated with recurrent
attacks in 13% of patients within 1 month of hospital discharge
and in 17% at a median of 18 weeks after the initial episode.19,20
In addition, recurrent admissions for BAP tend to increase
in length and are associated with greater morbidity.20,21 Thus,
omitting cholecystectomy in the presence of occult biliary disease
can be associated with significant morbidity, whereas early inter-
vention with laparoscopic cholecystectomy is safe and effectively
reduces recurrence rates.22
If cholecystectomy is not performed in patients with a high ALT
and negative AUS, a number of invasive, expensive and resource-
limited investigations are required, all of which can lead to signifi-
cant delays in definitive treatment. Yet, a significant proportion of
these patients will subsequently be found to have a biliary cause
and hence require cholecystectomy. A formal cost-effectiveness
analysis would be particularly useful to determine the most
appropriate approach.
It is probable that this current study significantly under-
diagnoses the incidence of gallstones in AP. Firstly, routine access
to EUS is not possible. Several studies have shown that EUS has a
greater sensitivity and specificity for BAP than AUS and reduces
the number of patients diagnosed with idiopathic disease. In
the current study, 24% of patients were of unknown aetiology,
compared with 7–11% in studies using EUS. One of these studies
found that EUS diagnosed cholecystolithiasis or choledocholi-
thiasis in 15% of patients with a negative AUS and CT.2,10,16,17 It was
Table 3 Demographics, alanine transaminase (ALT), predicted severity and outcome in patients with biliary and non-biliary acute pancreatitis
(BAP)
BAP Non-BAP P-value
n (%) 292 (54) 251 (46)
Median age, years (range) 63 (44–75) 51 (34–68) <0.001
Female, n (%) 168 (58) 115 (46) 0.006
Median ALT, units/l (range) 200 (63–421) 33 (18–84) <0.001
Median Apache II score, (range) 6 (3–9) 5 (2–7) <0.001
Median C-reactive protein, mg/l (range) 104 (18–222) 82 (11–223) 0.413
C-reactive protein > 150 mg/l, n (%) 118 (40) 91 (36) 0.269
Any necrosis on CT, n (%) 27 (9.3) 16 (6.4) 0.217
CT necrosis < 30%, n (%) 16 (5.5) 7 (2.8) 0.121
CT necrosis > 30%, n (%) 11 (3.8) 9 (3.6) 0.911
Death prior to discharge, n (%) 7 (1.3) 6 (1.1) 0.996
CT, computed tomography
Table 4 Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and likelihood ratio (LR) for gender, age and
alanine transaminase (ALT) in biliary acute pancreatitis
Sensitivity, % Specificity, % PPV, % NPV, % Positive LR Negative LR
Female 58 54 59 52 1.26 0.78
Male 42 46 48 41 0.78 1.26
Age > 50 years 67 49 60 56 1.31 0.67
Age > 60 years 54 67 66 56 1.64 0.69
ALT < 30 units/l 14 53 25 35 0.29 1.64
ALT > 100 units/l 66 79 79 67 3.20 0.43
ALT > 150 units/l 59 84 81 64 3.70 0.49
ALT > 300 units/l 36 94 87 56 5.66 0.68
ALT > 500 units/l 20 98 92 51 9.84 0.82
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difficult to assess the predictive value of AUS in the current study
as the investigation represents part of the reference standard such
that the result of the AUS influences the final diagnosis and deci-
sion for further investigations. The second reason for an underes-
timation of the true prevalence of biliary pancreatitis is that a
negative initial AUS may have falsely reassured the investigating
clinician and the patient may not have been followed up with
further investigations. Although magnetic resonance cholan-
giopancreatography (MRCP) has been shown to have similar
accuracy to ERCP in diagnosing BAP,23,24 this investigation is not
employed routinely in patients with a negative AUS and resolving
AP because of its limited availability. An underestimation of the
true prevalence of BAP may explain why the PPV for ALT pro-
duced in this study is lower than that reported in other similar
papers. If a number of the patients with a raised ALT were mis-
diagnosed as having non-biliary aetiology, the sensitivity and PPV
of the test would be underestimated.
In addition,ALTwithin the normal range reduces the likelihood
of gallstones in AP to 25%. The results of a recent review article
indicate that the LR for BAP associated with a negative AUS is
0.14–0.35.2Applying this to the current study population, a normal
ALT combined with a negative AUS reduces the likelihood of
gallstones to 4–10% (Table 6). Using the combination of these
two factors in the clinical setting would therefore reduce the need
for unnecessary cholecystectomy, thus reducing surgicalworkloads
and hospital waiting lists, as well as enabling a more rapid investi-
gation into alternative causes for the presenting pancreatitis.
It would have been useful to exclude patients with a history of
excessive alcohol consumption in order to increase the predictive
power of ALT for gallstones by increasing the pre-test probability.
However, this was not possible from the data available, which did
not separate a history of alcohol misuse from the final diagnosis,
which was based on history and appropriate investigations to
exclude other causes.
The study cohort includes all first episodes of AP presenting to
Christchurch Public Hospital between July 2005 and December
2008 and therefore accurately reflects the characteristics of the
local population. The study data and results may be generalized to
other communities with similar genetic and lifestyle risks for pan-
creatitis and with comparable hospital facilities (Western world
diet and genetics, low incidence of ethanol [EtOH]-induced pan-
creatitis, and a resource-limited, state-funded hospital system).
In conclusion, this large prospective study confirmed that ALT
is a useful marker for predicting gallstones in AP and that there is
a positive correlation between increasing ALT and likelihood of
Table 5 Post-alanine transaminase (ALT) probability of biliary cause for acute pancreatitis based on ALT in the total population and in
subgroups
Population
probability. %
Subgroup probability, %
Female Male Age >
50 years
Age >
60 years
Female >
50 years
Female >
60 years
Pre-test 54 59 48 60 66 63 66
Probability
ALT, units/l Positive
likelihood
ratio
<30 0.29 25 29 21 30 36 33 36
>50 2.3 72 76 68 77 81 79 82
>100 3.2 79 82 75 83 86 84 86
>150 3.7 81 84 77 85 88 86 88
>200 4.3 83 86 80 87 89 88 89
>300 5.6 87 89 84 89 92 91 92
>400 7.5 90 91 87 92 94 93 94
>500 9.8 92 93 90 94 95 94 95
Table 6 Post-abdominal ultrasound (AUS) probability of biliary cause
for acute pancreatitis at various alanine transaminase (ALT) thresh-
olds, based on likelihood ratios for AUS derived from the literature (2)
ALT, units/l Population
pre-AUS
probability, %
Post-positive
AUS probability,
%
Post-negative
AUS probability,
%
<30 25 76–80 4–10
>30 65 95–96 21–40
>50 72 96–97 26–47
>100 79 97–98 34–57
>150 81 98 37–60
>200 83 98 41–63
>250 87 98–99 48–70
>300 87 98–99 48–70
>350 89 99 53–74
>400 90 99 56–76
>450 92 99 62–80
>500 92 99 62–80
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BAP. Older age and female gender are also independent risk
factors for gallstones in AP. Abdominal ultrasound is highly spe-
cific, but has poor sensitivity for BAP and so is limited in its ability
to completely exclude this diagnosis. Thus, for patients in whom
ALT is elevated, proceeding to cholecystectomy without further
investigation should be considered. In addition, a combination of
positive AUS and elevated ALT gives an almost 100% confirma-
tory diagnosis of BAP.
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